Advertisement

Topics

SmartZyme Adds Two Drug Development Veterans to Broaden and Strengthen Leadership Team

10:00 EDT 5 Jul 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Mark Leavitt, Ph.D. Appointed Vice President of R&D and Chief Technology Officer Christopher R. Shepard, Ph.D. Appointed Senior Vice President of Business and Portfolio Development SmartZyme BioPharma, In...

Other Sources for this Article

SmartZyme Biopharma, Inc.
Geoffrey McGrane, 973-865-3837
Investor Relations & Business Development Manager
geoffrey@smzyme.com

NEXT ARTICLE

More From BioPortfolio on "SmartZyme Adds Two Drug Development Veterans to Broaden and Strengthen Leadership Team"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...